Skip to main content
Equibles

MIC Capital Management UK LLP

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1889830 LONDON, X0
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$1,222,743
-$523,038 QoQ
Shares Held
87,028
0.0% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#24
of 87 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MIC Capital Management UK LLP holds $143,782,490 across 4 Biotechnology names. LYEL ranks #4 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 531,733 $99,582,956
2 RXRX
Recursion Pharmaceuticals, Inc.
 9,644,033 $35,393,601
3 NMRA
Neumora Therapeutics, Inc.
 4,460,700 $7,583,190
4 LYEL
Lyell Immunopharma, Inc.
This page 		87,028 $1,222,743

All Filings in LYEL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,222,743 87,028
2026-03-31 $1,745,781 87,028
2025-12-31 $2,678,721 87,028
2025-09-30 $1,413,334 87,028
2025-06-30 $769,327 87,028
2025-03-31 $936,426 1,740,569
2024-12-31 $1,113,964 1,740,569
2024-09-30 $2,401,985 1,740,569
2024-06-30 $2,523,825 1,740,569
2024-03-31 $3,881,468 1,740,569
2023-12-31 $3,376,703 1,740,569
2023-09-30 $2,558,636 1,740,569
2023-06-30 $9,732,609 3,060,569
2023-03-31 $7,222,942 3,060,569
2022-12-31 $10,620,174 3,060,569
2022-09-30 $22,433,970 3,060,569
2022-06-30 $19,954,909 3,060,569
2022-03-31 $6,666,000 1,320,000
2021-12-31 $10,216,800 1,320,000

Report a Problem

Category
Description
Email (optional, for follow-up)